Invasive aspergillosis

References

• Caillot D, Casasnovas 0, Bernard A, et al. Improved manage-ment of invasive aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Gun Oncol 1997; 15: 139–147.
   Google Scholar
• Yeldandi V, Laghi F, McCabe MA, et al. Aspergillus and lung transplantation. J Heart Lung Transpl 1995; 14: 883–890.
   PubMed Web of Science ®Google Scholar
• Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171–178.
   PubMed Web of Science ®Google Scholar
• Aisner J, Schimpff SC, Wiemik PH. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to re-sponse. Ann Intern Med 1977; 86: 539–543.
   Google Scholar
• Martino P, Raccah R, Gentile G, Venditti M, Girmenia C, Mandelli F. Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. Haematologica 1989; 74: 263–265.
   PubMed Web of Science ®Google Scholar
• Nucci M, Biasoli I, Barreiros G, et al. Predictive value of a positive nasal swab for Aspergillus sp. in the diagnosis of invasive aspergillosis in adult neutropenic cancer patients. Di-agn Microbiol Infect Dis 1999; 35: 193–196.
   PubMed Web of Science ®Google Scholar
• Bretagne S, Costa JM, Marmorat-Khuong A, et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Gun Microbiol 1995; 33: 1164–1168.
   Google Scholar
• Melchers WJ, Verweij PE, van den Hurk P, et al. General primer-mediated PCR for detection of Aspergillus species. J Gun Microbiol 1994; 32: 1710–1717.
   Google Scholar
• Niesters HG, Goessens WH, Meis JF, Quint WG. Rapid, polymerase chain reaction-based identification assays for Can-dida species. J Gun Microbiol 1993; 31: 904–910.
   Google Scholar
• van Deventer AJ, Goessens WH, van Belkum A, van Vliet HJ, van Etten EW, Verbrugh HA. Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Gun Microbiol 1995; 33: 625–628.
   Google Scholar
• Miyakawa Y, Mabuchi T, Fukazawa Y. New method for detection of Candida albicans in human blood by polymerase chain reaction. J Gun Microbiol 1993; 31: 3344–3347.
   Google Scholar
• Walsh TJ, Francesconi A, Kasai M, Chanock SJ. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi. J Gun Microbiol 1995; 33: 3216–3220.
   Web of Science ®Google Scholar
• Einsele H, Hebart H, Roller G, et al. Detection and identifica-tion of fungal pathogens in blood by using molecular probes. J Gun Microbiol 1997; 35: 1353–1360.
   Web of Science ®Google Scholar
• Van Bunk JA, Myerson D, Schreckhise RW, Bowden RA. Panfungal PCR assay for detection of fungal infection in hu-man blood specimens. J Gun Microbiol 1998; 36: 1169–1175.
   Web of Science ®Google Scholar
• Loeffler J, Hebart H, Bialek R, et al. Contaminations occurring in fungal PCR assays. J Gun Microbiol 1999; 37: 1200–1202.
   Web of Science ®Google Scholar
• Verweij PE, Latgé JP, Rijs AJMM, et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Gun Mi-crobiol 1995; 33: 3150–3153.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Brinkman K, Kremers HPH, Kullberg BJ, Meis JFGM. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Gun Microbiol 1999; 37: 1186–1189.
   Google Scholar
• Le Moing V, Lortholary 0, Timsit JF, et al. Aspergillus peri-carditis with tamponade: report of a successfully treated case and review. Clin Infect Dis 1998; 26: 451–460.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Poulain D, Obayashi T, Patterson TF, Denning DW, Ponton J. Current trends in the detection of antigenemia, metabolites and cell wall markers for the diagnosis and thera-peutic monitoring of fungal infections. Med Mycol 1998; 36 (Suppl. I): 146–155.
   Google Scholar
• Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-con-trolled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillo-sis. J Gun Microbiol 1999; 37: 3223–3228.
   Web of Science ®Google Scholar
• Rohrlich P, Sarfati J, Mariani P, et al. Prospective sandwich enzyme linked immunosorbent assay for serum galactomannan: early predicitve value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996; 15: 232–237.
   PubMed Web of Science ®Google Scholar
• Maertens JA, Verhaegen J, Demuynck H, Van Eldere J, Verbist L, Boogaerts M. Prospective evaluation of serum galactoman-nan (GM) levels measured by a sandwich-ELISA technique in invasive aspergillosis (IA). 39th Interscience Conference on An-timicrobial Agents and Chemotherapy, San Francisco, 1999. Abstract 144.
   Google Scholar
• Verweij PE, Dompeling EC, Donnelly JP, Schattenberg AVMB, Meis JFGM. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investiga-tions with two examples. Infection 1997; 25: 86–89.
   Google Scholar
• Patterson TF, Miniter P, Patterson JE, Rappeport JM, Andri-ole VT. Aspergillus antigen detection in the diagnosis of inva-sive aspergillosis. J Infect Dis 1995; 171: 1553–1558.
   Google Scholar
• Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: biology, pathology, clinical counterparts and conse-quences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transpl 2000; 25: 1269–1278.
   Google Scholar
• Verweij PE, Weemaes CM, Curfs JHAJ, Bretagne S, Meis JFGM. Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive asper-gillosis. J Gun Microbiol 2000; 38: 3900–3901.
   Google Scholar
• Obayashi T, Yoshiba M, Mori T, et al. Plasma (1- > 3)-I3-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. fancet 1995; 345: 17–20.
   Google Scholar
• Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990; 12: 308–329.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Refer-ence method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Refer-ence method for broth dilution antifungal susceptibility testing of conidium forming filamnetous fungi. Proposed standard M38-P. Wayne, PA: National Committee for Clinical Labora-tory Standards, 1998.
   Google Scholar
• Meletiadis J, Kerremans J, Donnelly JP, Mouton JW, Meis JFGM, Verweij PE. Growth curves of filamentous fungi in different media. Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 2000: Abstract 209.
   Google Scholar
• Meletiadis J, Meis JFGM, Mouton JW, Donnelly JP, Verweij PE. Comparison of NCCLS and 3-(4,5-dimethy1-2-thiazy1)-2,5-dipheny1-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol 2000; 38: 2949–2954.
   Google Scholar
• Szekely A, Johnson EM, Warnock DW. Comparison of E-test and broth microdilution methods for antifungal drug suscepti-bility testing of molds. J Clin Microbiol 1999; 37: 1480–1483.
   Google Scholar
• Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608–615.
   PubMed Web of Science ®Google Scholar
• Sutton DA, Sanche SE, Revankar SG, Fothergill AW, Rinaldi MG. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head to head comparison to voriconazole. J Gun Microbiol 1999; 37: 2343–2345.
   Google Scholar
• Verweij PE, Mensink M, Rijs AJ, Donnelly JP, Meis JFGM, Denning DW. In vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Asper-gillus fumigatus isolates. J Antimicrob Chemother 1998; 42: 389–392.
   PubMed Web of Science ®Google Scholar
• Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH. Microdilution susceptibility testing of amphotericin B, itracona-zole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 1999; 37: 3946–3951.
   PubMed Web of Science ®Google Scholar
• Lass-Florl C, Kofler G, Kropshofer G, Hermans J, Kreczy A, Dierich MP, Niederwieser D. In vitro testing of susceptiblility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 1998; 42: 497–502.
   Google Scholar
• Verweij PE, Oakley KL, Morrissey J, Morrissey G, Denning DW. Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus furnigatus in a murine model of invasive aspergillosis. Antimicrob Agents Chemother 1998; 42: 873–878.
   Google Scholar
• Johnson EM, Oakley KL, Radford SA, et al. Lack of correla-tion of in vitro amphotericin B susceptibility testing with out-come in a murine model of Aspergillus infection. J Antimicrob Chemother 2000; 45: 85–93.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Field-Ridely A, Sutton D, et al. Aspergillus terreus: an emerging pathogen resistant to amphotericin B. Abstracts of the 14th ISHAM, May 8–12, 2000, Buenos Aires. ISHAM, 2000: Abstract 557.
   Google Scholar
• Christiansen KJ, Bernard EM, Gold JW, Armstrong D. Distri-bution and activity of amphotericin B in humans. J Infect Dis 1985; 152: 1037–1043.
   PubMed Web of Science ®Google Scholar
• Denning DW, Radford SA, Oakley KL, Hall L, Johnson EM, Warnock DW. Correlation between in vitro susceptibility test-ing to itraconazole and in vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chem.other 1997; 40: 401–414.
   PubMed Web of Science ®Google Scholar
• Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364–1368.
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Borel E, Persat F, Monier MF, Piens MA, EBGA Network (European research group on Biotypes and Genotypes of Aspergillus fumigatus). In vivo itraconazole resistance of Aspergillus fumigatus in a systemic murine aspergillosis model. J Med Microbiol 1999; 48: 1087–1093.
   Google Scholar
• Verweij PE, Rijs AJJM, Donnelly JP, Meis JFGM. Nationwide survey of in vitro activity of antifungal agents against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998 in the Netherlands. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1998: Abstract J–33.
   Google Scholar
• Tortorano AM, Dannaoui E, Meis J, et al. Antifungal suscepti-bility of 203 Aspergillus fumigatus isolates from patients under prolonged antifungal treatment. Abstracts of the 14th IS HAM, May 8–12, 2000, Buenos Aires, ISHAM, 2000; Abstract 456.
   Google Scholar
• Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982; 61: 109–124.
   Google Scholar
• Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. Semi-invasive' pulmonary aspergillosis. Radiology 1981; 140: 313–321.
   Google Scholar
• Washburn RG, Kennedy DW, Begley MG, Henderson DK, Bennett JE. Chronic fungal sinusitis in apparently normal hosts. Medicine 1988; 67: 231–247.
   Google Scholar
• DeShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med 1997; 337: 254–259.
   PubMedGoogle Scholar
• Karim M, Adam M, Shah AA, Ahmed R, Sheikh H. Chronic invasive aspergillosis in apparently immunocompetent hosts. Clin Infect Dis 1997; 24: 723–733.
   Google Scholar
• Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 1990; 23: 607–614.
   PubMed Web of Science ®Google Scholar
• Yanai Y, Wakao T, Fukamachi A, Kunimine H. Intracranial granuloma caused by Aspergillus fumigatus. Surg Neurol 1985; 23: 597–604.
   PubMedGoogle Scholar
• Mochizuki M, Murase S, Takahashi K, et al. Serum Itracona-zole and hydroxyitraconazole concentrations and interaction with digwdn in a case of chronic hypertrophic pachymeningitis caused by Aspergillus flavus. Jpn J Med Mycol 2000; 41: 33–39.
   Google Scholar
• Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine 1999; 78: 123–138.
   PubMed Web of Science ®Google Scholar
• Wald A, Leisenring W, van Bunk J-A, Bowden RA. Epidemiol-ogy of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459–1466.
   Google Scholar
• Jantunen E, Piilonen A, Volin L, Parkkali T, Koukila-Kähkölä P, Ruutu T, Ruutu P. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transpl 2000; 25: 867–871. 2000 SHAM, Medical Mycology, 38, Suppl. I, 215–224
   Google Scholar
• Kanj SS, Welty-Wolf K, Madden J, et al. Fungal infection in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine 1996; 75: 142–156.
   Google Scholar
• Collins LA, Samore MH. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J In-fect Dis 1994; 170: 644–652.
   Google Scholar
• Guillemain R, Lavarde V. Invasive aspergillosis after transplan-tation. Transpl Proc 1995; 27: 1307–1309.
   PubMedGoogle Scholar
• Leung AN, Gosselin MV, Napper CH, et al. Pulmonary infec-tions after bone marrow transplantation: clinical and radio-graphic findings. Radiology 1999; 210: 699–710.
   PubMed Web of Science ®Google Scholar
• Manuel RJ, Kibbler CC. The epidemiology and prevention of invasive aspergillosis. J Hosp Infect 1998; 39: 95–109.
   PubMed Web of Science ®Google Scholar
• Beyer J, Schwartz S. Strategies in prevention of invasive pul-monary aspergillosis in immunosuppressed or neutropenic pa-tients. Antimicrob Agents Chemother 1994; 38: 911–917.
   PubMed Web of Science ®Google Scholar
• Morris G, Kokki MH, Anderson K, Richardson MD. Sampling of Aspergillus spores in air. J Hosp Infect 2000; 44: 81–92.
   PubMed Web of Science ®Google Scholar
• Thio CL, Smith D, Mert WG, et al. Refinements of environ-mental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Contr Hosp Epidemiol 2000; 21: 18–23.
   PubMed Web of Science ®Google Scholar
• Richardson MD, Rennie S, Marshall I, et al. Fungal surveil-lance of an open haematology ward. J Hosp Infect 2000; 44: 1–5.
   PubMedGoogle Scholar
• Viscoli C. Prevention of aspergillosis in bone marrow trans-plantation. J Infect Dis 1998; 177: 1775–1776.
   PubMed Web of Science ®Google Scholar
• Warns A, Gaustad P, Voss A, Meis JFGM, Verweij PE, Abrahamsen TG. Water as a source of filamentous fungi in a childhood bone marrow transplantation unit. J Hosp Infect 2000 (in press).
   Google Scholar
• Anaissie El, Stratton SL, Summerbell RC, Monson TP, Rex JH, Walsh TJ. Aspergillus species aerosols in hospitals: shower-ing as a potential mode of exposure. Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemother-apy, September 26–29, 1999, San Francisco, CA Washington DC: American Society for Microbiology, 1999: 578.
   Google Scholar
• Leenders ACAP, Daenen S, Jansen RLH, et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associ-ated invasive fungal infections. Br J Haemato11998; 103: 205–212.
   PubMed Web of Science ®Google Scholar